M11.162
Familial chondrocalcinosis, left knee
Clinical Classification Guidelines
Medical Intelligence & Overview
Familial chondrocalcinosis, also known as calcium pyrophosphate dihydrate (CPPD) deposition disease, is a hereditary condition characterized by the abnormal accumulation of calcium deposits within the cartilage of joints. When this condition involves the left knee, it can cause joint pain, swelling, and stiffness. Typically inherited, familial chondrocalcinosis tends to affect multiple family members and may progress over time. Understanding this condition can help individuals recognize symptoms early and seek appropriate medical evaluation.
Causes & Symptoms
Clinical Causes: Genetic mutations passed down within families that affect calcium metabolism Inherited predisposition leading to abnormal calcium crystal formation within joint cartilage Age-related changes that may exacerbate the deposition of calcium crystals in the cartilage Other metabolic conditions that may influence calcium deposit formation (less common)
Key Symptoms: Joint pain, especially during movement or after periods of inactivity Swelling around the affected knee joint Stiffness, making it difficult to bend or straighten the knee Tenderness when touching the area around the joint Possible warmth or redness in the knee, indicating inflammation Recurrence of joint symptoms that can affect the same or different joints over time
Diagnostic & Treatment
Diagnosis Path: Diagnosing familial chondrocalcinosis involves a combination of medical history, physical examination, and imaging tests. X-rays of the knee can reveal characteristic calcium deposits within the cartilage. Joint fluid analysis, obtained through aspiration, may show calcium pyrophosphate crystals under microscopic examination. Genetic counseling and family history assessment are also integral to confirming the hereditary nature of the condition. Blood tests might be performed to rule out other causes of joint issues or to evaluate calcium and phosphate levels.
Treatment Protocols: While there is no cure for familial chondrocalcinosis, treatment focuses on managing symptoms and reducing joint inflammation. Approaches include: - **Medications:** Nonsteroidal anti-inflammatory drugs (NSAIDs) to relieve pain and inflammation, corticosteroids for acute flare-ups, and analgesics for pain management. - **Physical therapy:** Exercises to maintain joint mobility and strengthen muscles around the knee. - **Lifestyle modifications:** Maintaining a healthy weight to reduce stress on the joint, avoiding activities that exacerbate symptoms. - **Joint injections:** Corticosteroid injections for severe inflammation. - **Monitoring:** Regular follow-up with healthcare providers to monitor disease progression and adjust management strategies. In some cases, surgical interventions might be considered if joint damage becomes severe, though this is less common.
Clinical Advice & FAQs
Billing Guidance
Is M11.162 a billable ICD-10 code?
Yes, M11.162 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M11.162?
Clinical documentation must specify the nature of Familial chondrocalcinosis, left knee and any associated comorbidities for accurate reporting.
Cite this Clinical Reference